Stock of the Day

June 16, 2020

Teleflex (TFX)

$140.22
-$1.83 (-1.3%)
Market Cap: $5.94B

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Today's Trend

Teleflex Incorporated (NYSE: TFX) shares traded lower despite several favorable developments. The main investor focus is the company’s strong second-quarter operating performance, improved full-year EPS outlook and new share-repurchase authorization, although earnings declined substantially from the prior year and reported results included profitability pressure.

  • Teleflex announced a $250 million accelerated share repurchase agreement. The program should reduce the company’s share count and may support per-share earnings and investor sentiment. Teleflex Launches $250 Million Accelerated Share Repurchase
  • Second-quarter revenue rose 28.9% year over year to $570.3 million, exceeding the $559.6 million consensus estimate. Adjusted EPS of $1.76 also beat expectations of $1.28, providing evidence of better-than-expected operating performance. Teleflex Surpasses Q2 Earnings and Revenue Estimates
  • Teleflex raised or reaffirmed its fiscal 2026 adjusted EPS outlook at $6.90 to $7.20, above the $6.70 analyst consensus. Piper Sandler maintained an Overweight rating and increased its price target to $169 from $160, signaling additional potential upside. Piper Sandler Rating and Price Target
  • Teleflex declared a quarterly dividend of $0.34 per share, payable September 30 to shareholders of record August 14. The dividend provides ongoing shareholder returns, though its approximately 1% yield is unlikely to be a major short-term catalyst.
  • GAAP diluted EPS from continuing operations fell to $0.96 from $1.54 a year earlier, while adjusted EPS declined from $3.73. Teleflex also reported a negative net margin, which may be weighing on the stock despite the quarterly earnings beat. Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook
← Previous Stock of the DayNext Stock of the Day →